Raymond James Financial’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.8M Sell
314,204
-1,508
-0.5% -$105K 0.01% 1572
2026
Q1
$23.8M Sell
315,712
-19,286
-6% -$1.38M 0.01% 1342
2025
Q4
$20.7M Buy
334,998
+65,479
+24% +$3.85M 0.01% 1418
2025
Q3
$15.8M Buy
269,519
+8,897
+3% +$519K 0.01% 1581
2025
Q2
$15.2M Sell
260,622
-66,188
-20% -$3.74M 0.01% 1563
2025
Q1
$16.2M Buy
326,810
+15,320
+5% +$784K 0.01% 1469
2024
Q4
$13.9M Buy
+311,490
New +$14.8M 0.01% 1587

Other funds holding NTR

Raymond James Financial's NTR Position: Q2 2026 in Review

Raymond James Financial reduced its Nutrien (NTR) stake by 0.48% in Q2 2026, selling an estimated $105K and leaving 314,204 shares worth $19.8M. The position accounts for 0.01% of the portfolio, ranked #1572.

Raymond James Financial first reported a position in NTR in Q4 2024 and has held it in 7 quarters since. The position peaked at $23.8M in Q1 2026. 733 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Raymond James Financial held 314,204 shares of Nutrien worth $19.8M as of Q2 2026.
  • Raymond James Financial sold 1,508 Nutrien shares in Q2 2026, an estimated $105K.
  • Nutrien made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1572 holding.
  • Raymond James Financial first reported a position in Nutrien in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Nutrien position peaked at $23.8M in Q1 2026.
  • 733 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.